BIOMAT Database Logo BIOMAT Database Logo

Evidence for marked sensitivity to the antilipolytic action of insulin in obese maturity-onset diabetics. 1979

B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett

UI MeSH Term Description Entries
D007198 Indians, North American Members of indigenous North American populations with pre-colonial contact origins. Amerinds, North American,Indigenous North Americans,American Indian, North,American, Indigenous North,Amerind, North American,Indian, North American,Indigenous North American,North American Amerind,North American Amerinds,North American Indian,North American Indians,North American, Indigenous
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008053 Lipid Mobilization LIPOLYSIS of stored LIPIDS in the ADIPOSE TISSUE to release FREE FATTY ACIDS. Mobilization of stored lipids is under the regulation of lipolytic signals (CATECHOLAMINES) or anti-lipolytic signals (INSULIN) via their actions on the hormone-sensitive LIPASE. This concept does not include lipid transport. Lipid Mobilizations,Mobilization, Lipid,Mobilizations, Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005260 Female Females

Related Publications

B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
Insulin stimulating action of secretin in maturity onset diabetics.
March 1969, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
Insulin sensitivity and vascular disease in maturity-onset diabetics.
November 1969, British medical journal,
B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
[Contribution to the nutrition-dependent release of insulin in obese maturity-onset diabetics].
January 1968, Acta diabetologica latina,
B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
[The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].
April 1980, Wiener klinische Wochenschrift,
B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action.
March 1984, The Journal of clinical endocrinology and metabolism,
B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
[When should stable maturity-onset diabetics be switched to insulin?].
October 1980, Schweizerische medizinische Wochenschrift,
B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
Sensitivity to the antilipolytic action of insulin in non-insulin-dependent diabetes in the young.
December 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
May 1979, The Journal of clinical investigation,
B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
Effect of weight reduction on the glucose tolerance in obese maturity onset diabetics.
January 1977, The Journal of the Egyptian Public Health Association,
B V Howard, and P J Savage, and M Nagulesparan, and L J Bennion, and R H Unger, and P H Bennett
The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
May 1977, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!